Titre (en)
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration SRAS - Analysis (2020)

Index « Titre (en) » - entrée « angiotensin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
anesthetic < angiotensin < animal  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000002 (2020-04-15) Reinhold Kreutz [Allemagne] ; Engi Abd El-Hady Algharably [Allemagne] ; Michel Azizi [France] ; Piotr Dobrowolski [Pologne] ; Tomasz Guzik [Royaume-Uni] ; Andrzej Januszewicz [Pologne] ; Alexandre Persu [Belgique] ; Aleksander Prejbisz [Pologne] ; Thomas Günther Riemer [Allemagne] ; Ji-Guang Wang [République populaire de Chine] ; Michel Burnier [Suisse]Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19
000056 (2020) Paolo Verdecchia ; Gianpaolo Reboldi ; Claudio Cavallini ; Giovanni Mazzotta ; Fabio Angeli[ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
000218 (2020) Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis]Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
000219 (2020) Samuel James Brake [Australie] ; Kathryn Barnsley [Australie] ; Wenying Lu [Australie] ; Kielan Darcy Mcalinden [Australie] ; Mathew Suji Eapen [Australie] ; Sukhwinder Singh Sohal [Australie]Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).
000251 (2020) Shu-Ren Li [République populaire de Chine] ; Zi-Jian Tang [République populaire de Chine] ; Zai-Han Li [République populaire de Chine] ; Xuan Liu [République populaire de Chine]Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV.
000311 (2020) Marco Alifano [France] ; Pietro Alifano [Italie] ; Patricia Forgez [France] ; Antonio Iannelli [France]Renin-angiotensin system at the heart of COVID-19 pandemic
000312 (2020) Guido Iaccarino [Italie] ; Claudio Borghi [Italie] ; Arrigo F. G. Cicero [Italie] ; Claudio Ferri [Italie] ; Pietro Minuz [Italie] ; Maria Lorenza Muiesan [Italie] ; Paolo Mulatero [Italie] ; Giuseppe Mulè [Italie] ; Giacomo Pucci [Italie] ; Massimo Salvetti [Italie] ; Carmine Savoia [Italie] ; Leonardo Alberto Sechi [Italie] ; Massimo Volpe [Italie] ; Guido Grassi [Italie]Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension
000382 (2020) Ye Qiu ; Yuan-Bo Zhao ; Qiong Wang ; Jin-Yan Li ; Zhi-Jian Zhou ; Ce-Heng Liao ; Xing-Yi GePredicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2
000480 (2020) Allegra Battistoni ; Massimo VolpeMight renin-angiotensin system blockers play a role in the COVID-19 pandemic?
000509 (2020) Zaid Abassi [Israël] ; Suheir Assady [Israël] ; Emad E. Khoury [Israël] ; Samuel N. Heyman [Israël]Letter to the Editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications.
000540 (2020) Thorsten Kessler [Allemagne] ; Heribert Schunkert [Allemagne]Inhibitors of the renin–angiotensin system and SARS-CoV-2 infection
000783 (2020) Junyi Guo ; Zheng Huang ; Li Lin ; Jiagao LvCoronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
000870 (2020) Leo F. Buckley ; Judy W M. Cheng ; Akshay DesaiCardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin Converting Enzyme 2.
000993 (2020) Haibo Zhang [République populaire de Chine, Canada] ; Josef M. Penninger [Autriche] ; Yimin Li [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Arthur S. Slutsky [Canada, République populaire de Chine]Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
000994 (2020) David Gurwitz [Israël]Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.
000A97 (2004) Swee Kee Wong [États-Unis] ; Wenhui Li ; Michael J. Moore ; Hyeryun Choe ; Michael FarzanA 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "angiotensin" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "angiotensin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    angiotensin
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021